Skip to content

Clinical trials

Completed Prostatic Neoplasms, Castration-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms, Castration-Resistant Status: Completed Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20142
20153
20161
20173
20185
20192
20203
20211
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Michael Graham PhD, MD3
Janssen Research & Development, LLC2
MacroGenics2
Pfizer2
Radboud University Medical Center2
Arcus Biosciences, Inc.1
Boehringer Ingelheim1
Celgene1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms, Castration-Resistant26
Prostatic Neoplasms9
Bulbo-Spinal Atrophy, X-Linked1
Carcinoma, Ovarian Epithelial1
Carcinoma, Pancreatic Ductal1
Carcinoma, Renal Cell1
Liver Neoplasms1
Melanoma1
Neoplasms1

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.